Evidence map›Paper›PMID 14597695›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

SecA-dependent quality control of intracellular protein localization.

Markus Eser, Michael Ehrmann

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. SecA: a potential antimicrobial target.Future medicinal chemistry · 2015
    Review
  7. Article
  8. Article
  9. SecA, a remarkable nanomachine.Cellular and molecular life sciences : CMLS · 2011
    Review
  10. Review
  11. Review
  12. Target-directed proteolysis at the ribosome.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  13. Review
  14. SecB is a bona fide generalized chaperone in Escherichia coli.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Markus EserSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3US, United Kingdom.
Michael Ehrmann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex secretion machineries mediate protein translocation across cellular membranes. These machines typically recognize their substrates via signal sequences, which are required for proper targeting to the translocon. We report that during posttranslational secretion the widely conserved targeting factor SecA performs a quality-control function that is based on a general chaperone activity. This quality-control mechanism involves assisted folding of signal sequenceless proteins, thereby excluding them from the secretion process. These results suggest that SecA channels proteins into one of two key pathways, posttranslational secretion or folding in the cytoplasm. Implications of this finding for intracellular protein localization are discussed.

Indexed as

Bacterial ProteinsAdenosine TriphosphatasesAlkaline PhosphataseAmylasesCitrate (si)-SynthaseCyclin-Dependent KinasesEscherichia coliEscherichia coli ProteinsHydrogen-Ion ConcentrationMembrane Transport ProteinsProtein FoldingProtein TransportSecA ProteinsSEC Translocation ChannelsTemperatureTime FactorsAdenosine TriphosphatasesAlkaline PhosphataseAmylasesBacterial ProteinsCitrate (si)-SynthaseCyclin-Dependent KinasesEscherichia coli ProteinsMalS protein, E coliMembrane Transport ProteinsphoA protein, E coliSecA ProteinsSEC Translocation Channels

Identifiers

PMID14597695
PMCPMC263763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.